Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
a little hard of hearing; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (a little hard of hearing) in an 82-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (a little hard of hearing). At the time of the report, HYPOACUSIS (a little hard of hearing) outcome was unknown. No concomitant medication was reported. The patient had a little hard of hearing. She had nothing but Moderna shots since the pandemic came along, except for one last 2-Dec-2024 she had Pfizer. She was looking for mNEXSPIKE. She had been able to tolerate the vaccine before fairly well; she was just hoping that mNEXSPIKE might had a little bit less side effects, such as maybe 2 days in bed instead of 3 days in bed or something like that compared to Spikevax. It was unknown if the patient experienced any additional symptoms or events. No treatment medication was reported.